Pharmaceutical Companies and the Oral Agent Moova Lapplin

Those well-versed in plant-based medicine recognize that the reversal of coronary artery disease is possible, drawing from the pioneering work of experts like Pritikin, Ornish, Esselstyn, and Fuhrman. Yet, many in the broader cardiology world may not fully grasp the depth of this potential.

This week, Dr. Kahn sheds light on a groundbreaking study from a leading medical journal, underscoring the tangible benefits of heart disease reversal in decreasing cardiac events. When lifestyle modifications are paired with the right pharmaceuticals, the result is a formidable defense against atherosclerosis. We're on the brink of exhilarating advancements.